ישראל -
עברית -
Ministry of Health
רנקסה 1000 מ"ג
neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.
ישראל -
עברית -
Ministry of Health
רנקסה 1000 מ"ג
neopharm ltd - ranolazine 1000 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.
ישראל -
עברית -
Ministry of Health
רנקסה 500 מ"ג
neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.
ישראל -
עברית -
Ministry of Health
רנקסה 500 מ"ג
neopharm ltd - ranolazine 500 mg - tablets extended release - ranolazine - ranexa is indicated for the treatment of chronic angina. ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ace inhibitors, and angiotensin receptor blockers.
ישראל -
עברית -
Ministry of Health
percutaneous transluminal valvuloplasty
סלע מדיקל בע"מ - רופא - בלון וקס להרחבת שסתומים בלב
ישראל -
עברית -
Ministry of Health
טרנסלרנה 1000 מג
medison pharma ltd - ataluren - גרנולות להכנת תרחיף פומי - ataluren 1000 mg - ataluren
ישראל -
עברית -
Ministry of Health
טרנסלרנה 1000 מג
medison pharma ltd - ataluren - גרנולות להכנת תרחיף פומי - ataluren 1000 mg - ataluren
ישראל -
עברית -
Ministry of Health
טרנסלרנה 1000 מג
medison pharma ltd - ataluren - גרנולות להכנת תרחיף פומי - ataluren 1000 mg - ataluren
ישראל -
עברית -
Ministry of Health
טרנסלרנה 1000 מג
medison pharma ltd - ataluren - גרנולות להכנת תרחיף פומי - ataluren 1000 mg - ataluren
ישראל -
עברית -
Ministry of Health
טרנסלרנה 1000 מג
medison pharma ltd - ataluren - גרנולות להכנת תרחיף פומי - ataluren 1000 mg - ataluren